Search
for
Sort by
Research 211–240 of 325
- Letter to the Editor Etiquette
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- The causes of age-related alopecia from the point of view of modern morphology
- Skin Disorders in Athletes: Professional and Recreational Sports
- All Roads Go to the Nucleus: Integration of Signaling/Transcription Factor-Mediated and Epigenetic Regulatory Mechanisms in the Control of Skin Development and Regeneration
- Primary cicatricial alopecia
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Oral Retinoids in Dermatology
- Alopecia areata update
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Primary Cicatricial Alopecias
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- British Hair and Nail Society
- Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases
- Endocrine profile of the VCD-induced perimenopausal model rat
- Causal Link of Distinct Mental Disorders with Androgenetic Alopecia and Alopecia Areata: A Bidirectional Two-Sample Mendelian Randomization Study
- Radiofrequency Microneedling: A Comprehensive and Critical Review
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- Effects of photoperiod change on serum hormone level, hair follicle growth and antioxidant status in skin tissue of cashmere goats
- Cicatricial Alopecia Symposium 2011: Lipids, Inflammation and Stem Cells
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Transforming Growth Factor-β Receptor Type I and Type II Expression During Murine Hair Follicle Development and Cycling
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Dermoscopy of alopecia areata in restrospective analysis
- Dermal Papilla Cells: From Basic Research to Translational Applications
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Wound-Induced Hair Neogenesis Model
- Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide
- Proliferative and Non-Proliferative Lesions of the Rat and Mouse Integument